STOCK TITAN

LIGAND PHARMS CVR (LGNDZ) Stock Price, News & Analysis

LGNDZ OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
52 74 sessions, September 15, 2025 to September 16, 2026
Largest daily move
+92.5% close of October 14, 2025
1-year change
-69.7% closing prices, September 15, 2025 to September 16, 2026
1-month change
+21.1% closing prices, August 7, 2026 to September 16, 2026

Company Description

LGNDZ has declined 69.7% over the past year. The last closing price was $0.0023.

For FY2025, LIGAND PHARMS CVR reported revenue of $268.1M with net income of $124.5M and diluted earnings per share of $6.13. The company operates at a net profit margin of 46.4%.

This page collects what Stock Titan holds for LGNDZ, including price data, SEC filings, financial highlights, and short interest trends.

Stock Performance

$—
-
-
Last updated:
-69.7%
Performance 1 year

LIGAND PHARMS CVR (LGNDZ) closed at $0.0023 on September 16, 2026. Over the past 12 months, the price has lost 69.7%.

See what a $1,000 investment in LGNDZ would be worth today

LGNDZ Metrics & Rankings

Month to date
+21.1%
View ranking
YTD
-67.1%
View ranking

Price returns through September 16, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

No recent news available for LGNDZ.

Financial Highlights

LIGAND PHARMS CVR generated $268.1M in revenue in FY2025, operating income reached $41.0M (15.3% operating margin), and net income was $124.5M, reflecting a 46.4% net profit margin. Diluted earnings per share stood at $6.13. The company generated $49.4M in operating cash flow. The current ratio was 22.23, measuring current assets divided by current liabilities.

$268.1M
Revenue (FY2025)
$124.5M
Net Income (FY2025)
$49.4M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in LIGAND PHARMS CVR (LGNDZ) currently stands at 25 shares, representing 0.0% of the shares outstanding. Since October 2025, short interest has decreased by 99.9%.

Days to Cover History

Last 12 Months

Days to cover for LIGAND PHARMS CVR (LGNDZ) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.

Frequently Asked Questions

What is the current quoted price of LIGAND PHARMS CVR (LGNDZ)?

The current quoted price of LIGAND PHARMS CVR (LGNDZ) is $0.0023 as of September 16, 2026.

What is the revenue of LIGAND PHARMS CVR (LGNDZ) stock?

The FY2025 revenue of LIGAND PHARMS CVR (LGNDZ) is $268.1M, from its most recent completed fiscal year.

What is the net income of LIGAND PHARMS CVR (LGNDZ)?

The FY2025 net income of LIGAND PHARMS CVR (LGNDZ) is $124.5M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of LIGAND PHARMS CVR (LGNDZ)?

The diluted earnings per share (EPS) of LIGAND PHARMS CVR (LGNDZ) is $6.13 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of LIGAND PHARMS CVR (LGNDZ)?

The operating cash flow of LIGAND PHARMS CVR (LGNDZ) is $49.4M. Learn about cash flow.

What is the profit margin of LIGAND PHARMS CVR (LGNDZ)?

The net profit margin of LIGAND PHARMS CVR (LGNDZ) is 46.4%. Learn about profit margins.

What is the operating margin of LIGAND PHARMS CVR (LGNDZ)?

The operating profit margin of LIGAND PHARMS CVR (LGNDZ) is 15.3%. Learn about operating margins.

What is the current ratio of LIGAND PHARMS CVR (LGNDZ)?

The current ratio of LIGAND PHARMS CVR (LGNDZ) is 22.23, measuring current assets divided by current liabilities. Learn about liquidity ratios.

What is the operating income of LIGAND PHARMS CVR (LGNDZ)?

The operating income of LIGAND PHARMS CVR (LGNDZ) is $41.0M. Learn about operating income.